The assay is the first on the firm's isothermal nucleic acid amplification-based platform.
Deals with Quest and LabCorp and an expanded product offering also spurred the investment bank to increase its price target on Cepheid's stock to $75 per share from $52.
Bio-Rad scientist Jennifer Berman explains how ddPCR can help detect the basic efficiency of CRISPR/Cas9 and other genome editing technologies and more.
Alfa Aesar offers research chemicals for DNA-, RNA-, and PCR-based research, products for DNA and protein labeling, and proteomics reagents and kits.
A proof-of-principle study demonstrated the method's effectiveness by assaying samples spiked with avian influenza virus using a handheld device.
In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.
An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.
Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.
US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.
This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.